Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Daraprim

Daraprim

Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
Health

Martin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices

By Laura Lorenzetti
February 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership

Martin Shkreli Asks Court to Consider Blocking Subpoena

By Reuters
January 23, 2016
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Finance

Here’s How Much Martin Shkreli Is Actually Worth

By Jen Wieczner
January 8, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli’s Twitter Account Hacked

By Reuters and Aaron Task
December 21, 2015
US-CRIME-JUSTICE-SHKRELI
Health

Turing Replaces Martin Shkreli with Interim CEO

By Laura Lorenzetti
December 18, 2015
US-CRIME-JUSTICE-SHKRELI
Health

Martin Shkreli Is Reportedly Stepping Down as Turing CEO

By Benjamin Snyder
December 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership

Martin Shkreli’s 15 Minutes Are Up

By Geoff Colvin
December 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Health

How Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest

By Reuters
December 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Finance

Pharma CEO Martin Shkreli Arrested for Securities Fraud

By Geoffrey Smith
December 17, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Express Scripts is Taking on Turing Pharmaceuticals’ 5,000% Price Hike

By Claire Groden
December 1, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Turing Offers Hospitals Discounts on Daraprim Price

By Laura Lorenzetti
November 25, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Turing Says it Will Lower Daraprim Price by the End of the Year

By Laura Lorenzetti
November 4, 2015
Why the drug price scandal won’t be enough to keep down prices
Retail

Why the drug price scandal won’t be enough to keep down prices

By Laura Lorenzetti
October 26, 2015
Imprimis Turing Drug
Health

This company is offering a $1 alternative to Turing’s $750 drug

By Laura Lorenzetti
October 23, 2015
MSMB Capital Management CIO Martin Shkreli
Health

This super-expensive drug is getting a $1 rival

By Benjamin Snyder
October 23, 2015

Most Popular

  • Economy
    America’s $38 trillion national debt is so big the nearly $1 trillion interest payment will be larger than Medicare soon
    By Shawn Tully
  • Europe
    Americans have been quietly plundering Greenland for over 100 years, since a Navy officer chipped fragments off the...
    By Paul Bierman and The Conversation
  • Politics
    The Nobel Prize committee doesn't want Trump getting one, even as a gift—but they treated Obama very differently
    By Nick Lichtenberg
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.